{"uri":"study-on-peripheral-blood-mir-155-expression-in-pa-tmkek4w","version_id":"0","protocol_name":"Study on peripheral blood miR-155 expression in patients with type 2 diabetes mellitus and its relationship with vascular complications","protocol_name_html":"Study on peripheral blood miR-155 expression in patients with type 2 diabetes mellitus and its relationship with vascular complications","is_retracted":"0","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"0","last_modified":"1537012622","type_id":"1","link":null,"fork_id":"","public_fork_note":null,"number_of_steps":"7","has_versions":"0","first_published_date":null,"publish_date":"2018-09-15 11:57:02","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"10","mod_secs":"53","description":"{\"blocks\":[{\"key\":\"fge5m\",\"text\":\"Objective: To evaluate the expression of miR-155, nuclear factor kappa B (NF-\u03baB) and soluble intercellular adhesion molecule-1 (sICAM-1) in the peripheral blood of patients with type 2 diabetes mellitus (T2DM) and assess its relationship with diabetic vascular lesions.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":10,\"style\":\"align-left\"},{\"offset\":11,\"length\":258,\"style\":\"align-left\"},{\"offset\":0,\"length\":10,\"style\":\"bold\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"3h9tp\",\"text\":\" \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4oph7\",\"text\":\"Methods: A total of 165 T2DM patients and 60 healthy patients were included. Patients were divided into two groups: a simple T2DM group and a T2DM with vascular lesion group. The latter was further divided into a microvascular lesion group, a macrovascular lesion group and a microvascular combined with macrovascular lesion group. Albuminuria levels were divided into three groups as follows: <30 mg \/ 24 h, normal albuminuria group (NAU group); 30-300 mg \/ 24 h, microalbuminuria group (MAU group); and \u2265300 mg \/ 24 h, large albuminuria group (LAU group). Levels of peripheral blood miR-155, NF-\u03baB, and sICAM-1 were detected by RT-PCR[SE .\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":639,\"style\":\"align-left\"},{\"offset\":640,\"length\":1,\"style\":\"align-left\"},{\"offset\":0,\"length\":9,\"style\":\"bold\"}],\"entityRanges\":[{\"offset\":630,\"length\":6,\"key\":0},{\"offset\":636,\"length\":3,\"key\":1}],\"data\":{}},{\"key\":\"f2ddb\",\"text\":\"Results:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":8,\"style\":\"align-left\"},{\"offset\":0,\"length\":8,\"style\":\"bold\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"3eblj\",\"text\":\"\u2460Compared with that in the control group, the expression of miR-155, NF-\u03baB, and sICAM-1 in the T2DM group was significantly increased [(1.00\u00b10.12) vs. (1.82\u00b10.71), (1.04\u00b10.33) vs. (2.28\u00b10.66), (1.03\u00b10.30) vs. (1.88\u00b10.80), respectively; P<0.05].\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":244,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"2avpm\",\"text\":\"\u2461The levels of miR-155, NF-\u03baB, and sICAM-1 were significantly higher in the T2DM vascular lesion group than in the simple T2DM group [(1.95\u00b10.73) vs. (1.34\u00b10.29), (2.40\u00b10.65) vs. (1.65\u00b10.16), (2.01\u00b10.77) vs. (1.07\u00b10.41), respectively; P<0.05].\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":243,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"7slvc\",\"text\":\"\u2462The expression of miR-155 in the microvascular combined with macrovascular lesion group was higher than that in the macrovascular lesion group [(2.36\u00b10.61) vs. (1.77\u00b10.59); P<0.05], and the level of NF-\u03baB in the former group was significantly higher than those in the microvascular and macrovascular lesion groups (P<0.05).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":324,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"1ea9c\",\"text\":\"\u2463Compared with that in the NAU group, the level of miR-155 was significantly increased in the MAU and LAU groups [(1.04\u00b10.20) vs. (1.41\u00b10.49) vs. (2.64\u00b10.52), respectively; p<0.05], and the miR-155 level in the LAU group was higher than that in the MAU group (P<0.05).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":268,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"ft1mt\",\"text\":\"\u2464Pearson correlation analysis showed that miR-155 was positively correlated with NF-\u03baB and sICAM-1 (R=0.259, 0.67; P<0.01).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":123,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"8n22k\",\"text\":\"Conclusions: miR-155 expression was increased in T2DM patients and vascular lesions, consistent with the increasing trends observed for NF-\u03baB and sICAM-1. These findings suggest that miR-155 may be involved in the occurrence and development of diabetic chronic vascular disease.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":12,\"style\":\"align-left\"},{\"offset\":13,\"length\":265,\"style\":\"align-left\"},{\"offset\":0,\"length\":12,\"style\":\"bold\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"161og\",\"text\":\"     \\n \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"url\":\"\"}},\"1\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"url\":\"\"}}}}","is_bookmarked":"0","can_reassign":"1","before_start":"{\"blocks\":[{\"key\":\"clg9s\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","has_guidelines":"1","materials":[],"materials_text":"{\"blocks\":[{\"key\":\"5ahtt\",\"text\":\"Subjects and Methods\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":20,\"style\":\"align-left\"},{\"offset\":0,\"length\":20,\"style\":\"bold\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"7a2sp\",\"text\":\"One hundred sixty-five T2DM patients were randomly selected at the endocrinology department of the General Hospital of Tianjin Medical University and Teda International Vascular Hospital from June 2016 to June 2018. The subjects included 90 males and 75 females, and their average age was 61.79\u00b110.55 years. At the same time, 60 nondiabetic subjects matched for age, sex and body mass index (BMI) were selected. All subjects provided written consent to participate in the study.  -size:14.0pt;line-height:200%'>onsent to participate in the study. The study protocol was approved by the Independent Ethics Committee (IEC) of Teda International Cardiovascular Hospital. The registration institution is the Chinese Clinical Trial Registry, and the registration number is ChiCTR-ROC-17010468.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"enhth\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"a897\",\"text\":\"Diabetes diagnostic criteria:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":29,\"style\":\"bold\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"5f73h\",\"text\":\"All subjects met the WHO diagnostic criteria for T2DM (1999).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":61,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"4i515\",\"text\":\"Complications diagnostic criteria:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":34,\"style\":\"align-left\"},{\"offset\":0,\"length\":34,\"style\":\"bold\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"8jmvj\",\"text\":\"T2DM vascular lesions were diagnosed according to type 2 diabetes prevention and treatment strategies of China (2013) as follows: macrovascular lesions confirmed by electrocardiogram \/ coronary angiography, head CT\/MRI or peripheral vascular color Doppler ultrasonography or a history of cardio cerebral vascular disease; fundus examination (e.g., microangioma, bleeding, exudation) or 24-h urine albumin (24 h UAlb) quantitative examination to assure microvascular lesions.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":474,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"38l6d\",\"text\":\"Exclusion criteria: \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":19,\"style\":\"align-left\"},{\"offset\":0,\"length\":19,\"style\":\"bold\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"a8avr\",\"text\":\"Subjects with acute complications of diabetes, infection, tumor, primary liver disease or nondiabetic nephropathy were excluded from the study.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":143,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"8mds\",\"text\":\"Grouping:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":9,\"style\":\"align-left\"},{\"offset\":0,\"length\":9,\"style\":\"bold\"}],\"entityRanges\":[],\"data\":{}},{\"key\":\"8gc9v\",\"text\":\"Participants were allocated into a simple T2DM group and a T2DM with vascular lesion group, and the latter group was further divided into a microvascular lesion group, a macrovascular lesion group, and a microvascular combined with macrovascular lesion group. Participants were also classified into a normal albuminuria group (NAU group), a microalbuminuria group (MAU group) and a large albuminuria \ufffd\\u000f\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"offset\":0,\"length\":402,\"style\":\"align-left\"}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","warning":"{\"blocks\":[{\"key\":\"1m21a\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","version_class":"15756","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1536934704","protocol_affiliation":"Department of Endocrinology, Teda International Cardiovascular Hospital, Tianjin, China","affiliation":"TEDA international cardiovascular hospital","doi":"dx.doi.org\/10.17504\/protocols.io.tmkek4w","doi_status":"1","changed_fork_steps":null,"profile_url":"y2v28403v2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/012.png","full_name":"Liting Guo","created_by":"Liting Guo","private_link":"60FEB0D6B881F5693D71FA4B1B91BDD0","original_img":"1","username":"liting-guo","retraction_reason":null,"plos_id":null,"manuscript_citation":null,"journal_name":null,"journal_link":null,"is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":355780,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"Diabetes mellitus, type 2; Inflammation; Vascular lesions; MicroRNA-155; Microalbuminuria","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"2","badge_image":"\/img\/badges\/bronze.svg","badge_description":"Author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"liting Guo","authors_list":[{"name":"liting Guo","affiliation":"Department of Endocrinology, Teda International Cardiovascular Hospital, Tianjin, China","username":"liting-guo1","profile_image":"\/img\/avatars\/006.png"}],"user":{"profile_image":"\/img\/avatars\/012.png","username":"liting-guo","full_name":"Liting Guo","created_by":"Liting Guo"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":"{\"blocks\":[{\"key\":\"f8h9q\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","status_id":"1","is_research":"1","status_info":"We use this protocol in our group and it is working","steps":[{"id":"664513","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"86454AC0B82C11E88FCE2BE849BC10A5","previous_guid":null,"data":"{\"blocks\":[{\"key\":\"crm8c\",\"text\":\"One hundred sixty-five T2DM patients were randomly selected at the endocrinology department of the General Hospital of Tianjin Medical University and Teda International Vascular Hospital from June 2016 to June 2018. The subjects included 90 males and 75 females, and their average age was 61.79\\u00b110.55 years. At the same time, 60 nondiabetic subjects matched for age, sex and body mass index (BMI) were selected. All subjects provided written consent to participate in the study.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":[]}","section":"Sujects","case_id":null,"protocol_id":"15756","previous_id":"0","last_modified":null},{"id":"664516","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"ADA53F80B82C11E88FCE2BE849BC10A5","previous_guid":null,"data":"{\"blocks\":[{\"key\":\"eerfm\",\"text\":\"One hundred sixty-five T2DM patients were randomly selected at the endocrinology department of the General Hospital of Tianjin Medical University and Teda International Vascular Hospital from June 2016 to June 2018. The subjects included 90 males and 75 females, and their average age was 61.79\\u00b110.55 years. At the same time, 60 nondiabetic subjects matched for age, sex and body mass index (BMI) were selected. All subjects provided written consent to participate in the study.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":[]}","section":null,"case_id":null,"protocol_id":"15756","previous_id":"0","last_modified":null},{"id":"664523","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"F72307A0B82C11E88FCE2BE849BC10A5","previous_guid":"86454AC0B82C11E88FCE2BE849BC10A5","data":"{\"blocks\":[{\"key\":\"9ldbj\",\"text\":\"All subjects met the WHO diagnostic criteria for T2DM (1999).Complications diagnostic criteria:T2DM vascular lesions were diagnosed according to type 2 diabetes prevention and treatment strategies of China (2013) as follows: macrovascular lesions confirmed by electrocardiogram \\\/ coronary angiography, head CT\\\/MRI or peripheral vascular color Doppler ultrasonography or a history of cardio cerebral vascular disease; fundus examination (e.g., microangioma, bleeding, exudation) or 24-h urine albumin (24 h UAlb) quantitative examination to assure microvascular lesions.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":[]}","section":"Incriteria","case_id":null,"protocol_id":"15756","previous_id":"664513","last_modified":null},{"id":"664524","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"3E426D60B82D11E88FCE2BE849BC10A5","previous_guid":"F72307A0B82C11E88FCE2BE849BC10A5","data":"{\"blocks\":[{\"key\":\"7hp0b\",\"text\":\"Subjects with acute complications of diabetes, infection, tumor, primary liver disease or nondiabetic nephropathy were excluded from the study.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":[]}","section":"Exclusion criteria","case_id":null,"protocol_id":"15756","previous_id":"664523","last_modified":null},{"id":"664525","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"67645D70B82D11E88FCE2BE849BC10A5","previous_guid":"3E426D60B82D11E88FCE2BE849BC10A5","data":"{\"blocks\":[{\"key\":\"d9jq0\",\"text\":\"Participants were allocated into a simple T2DM group and a T2DM with vascular lesion group, and the latter group was further divided into a microvascular lesion group, a macrovascular lesion group, and a microvascular combined with macrovascular lesion group. Participants were also classified into a normal albuminuria group (NAU group), a microalbuminuria group (MAU group) and a large albuminuria group (LAU group).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":[]}","section":"Grouped","case_id":null,"protocol_id":"15756","previous_id":"664524","last_modified":null},{"id":"664526","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"85825370B82D11E88FCE2BE849BC10A5","previous_guid":"67645D70B82D11E88FCE2BE849BC10A5","data":"{\"blocks\":[{\"key\":\"3dotv\",\"text\":\"General data: All subjects were asked for details about their height, weight, blood pressure and BMI. Lipid, fasting plasma glucose, and glycosylated hemoglobin levels as well as liver and kidney functions were detected. The 24-h urine albumin level was measured, and fundus photography was examined. Information that identified individual participants during or after data collection was obtained when needed.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":[]}","section":"Methods","case_id":null,"protocol_id":"15756","previous_id":"664525","last_modified":null},{"id":"664530","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"ABB9CDC0B82D11E88FCE2BE849BC10A5","previous_guid":"85825370B82D11E88FCE2BE849BC10A5","data":"{\"blocks\":[{\"key\":\"b6397\",\"text\":\"RT-PCR methods:(1) Extraction of peripheral blood total RNA: The TRIzol method was used to extract total RNA according to the manufacturer\\u2019s instructions. The RNA concentration was measured using an ultraviolet spectrophotometer, and samples with a 260\\\/280 ratio between 1.8 and 2.1 were preserved at -80\\u00baC.(2) cDNA product: miR-155 and internal reference U6 primers were purchased from Guangzhou Ribo Biotechnology Company. The reverse transcriptase system (in which miR-155 uses the stem ring method) comprised the following: 1 \\u00b5l of dNTP (10 mM), 0.5 \\u00b5l of the target gene reverse transcriptase primer, 0.5 \\u00b5l of the internal parameter reverse transcriptase primer, 0.5 \\u00b5l of RNase inhibitor, 1 \\u00b5l of M-MLV, 4 \\u00b5l of 5\\u00d7 buffer and 2 \\u00b5g of total RNA in DEPC water at a total volume of 12.5 \\u00b5l; the mixture was incubated at 42\\u00baC for 60 min and at 70\\u00baC for 15 min. The cDNA product was maintained at -20\\u00baC.(3) The fluorescence quantitative RT-PCR system (cDNA diluted 10 times) comprised the following: 9 \\u00b5l of 2.5\\u00d7 SYBR Green Master Mix, 1 \\u00b5l of the upstream primer, 1 \\u00b5l of the downstream primer, 3 \\u00b5l of cDNA, and 6 \\u00b5l of DEPC water. The RT-PCT conditions for amplifying miR-155, U6 and sICAM-1 were as follows: predenaturation at 95\\u00b0C for 20 s; 40 cycles of denaturation at 95\\u00b0C for 10 s, annealing at 60\\u00b0C for 20 s, and extension at 72\\u00b0C for 15 s; and extension at 72\\u00b0C for 5 min. The NF-\\u03baB and GAPDH annealing conditions were 57\\u00b0C for 20 s; all other conditions were as described above.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":[]}","section":"Methods","case_id":null,"protocol_id":"15756","previous_id":"664526","last_modified":null}]}